Literature DB >> 19700478

Capecitabine-induced pancreatitis.

Hanifi Yucel1, Laurence V Warmerdam.   

Abstract

Capecitabine is an oral pro-drug of fluorouracil, which is a commonly used cytotoxic drug in the treatment of colorectal carcinoma. Many adverse effects are known to occur with capecitabine including diarrhea, palmar-planter erythrodysesthesia and nausea. We report a case of capecitabine-induced pancreatitis, also occurring with re-challenge.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19700478     DOI： 10.1177/1078155209344650

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN： 1078-1552            Impact factor:   1.809


  5 in total

Review 1.  Drug-induced pancreatitis.

Authors:  Claudia Nitsche; Sandrina Maertin; Jonas Scheiber; Christoph A Ritter; Markus M Lerch; Julia Mayerle
Journal:  Curr Gastroenterol Rep       Date:  2012-04

2.  The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective study.

Authors:  C O Michie; M Sakala; I Rivans; M W J Strachan; S Clive
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

3.  Chemotherapy-induced fulminant acute pancreatitis in pancreatic carcinoma: A case report.

Authors:  Linghui Lu; Yanni Lou; Huangying Tan
Journal:  Oncol Lett       Date:  2014-07-04       Impact factor: 2.967

4.  Lethal cardiotoxicity, steatohepatitis, chronic pancreatitis, and acute enteritis induced by capecitabine and oxaliplatin in a 36-year-old woman.

Authors:  Simona Gurzu; Ioan Jung; Maria Comsulea; Zoltan Kadar; Leonard Azamfirei; Calin Molnar
Journal:  Diagn Pathol       Date:  2013-09-16       Impact factor: 2.644

Review 5.  Current cancer therapies and their influence on glucose control.

Authors:  Carly Yim; Kerry Mansell; Nassrein Hussein; Terra Arnason
Journal:  World J Diabetes       Date:  2021-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.